BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-07-31
• Last 15 days FTD volume: A$0.03 M
• Last 3 months FTD volume: A$2.94 M
• Last 12 months FTD volume: A$8.78 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	A$7.76 M	A$0.10 B	🇺🇸 USA
GSK plc GSK	A$37.06 M	A$0.18 B	🇬🇧 UK
Sarepta Therapeutics SRPT	A$5.9 M	A$21.62 M	🇺🇸 USA
Repligen RGEN	A$28.47 M	A$47.74 M	🇺🇸 USA
Novavax NVAX	A$16.73 M	A$54.44 M	🇺🇸 USA
Celldex Therapeutics CLDX	A$0.73 M	A$11.2 M	🇺🇸 USA
NanoViricides NNVC	A$1.13 M	A$3.26 M	🇺🇸 USA
Cel-Sci CVM	A$1.1 M	A$3.21 M	🇺🇸 USA
Emergent BioSolutions EBS	A$4.21 M	A$7.02 M	🇺🇸 USA